Suppr超能文献

肺功能对产后使用皮质类固醇预防和治疗支气管肺发育不良的反应。

Lung function response to postnatal corticosteroids for the prevention and treatment of bronchopulmonary dysplasia.

作者信息

Rigotti Camilla, Zannin Emanuela, Chiaraluce Sofia, Ventura Maria Luisa

机构信息

Neonatal Intensive Care Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.

出版信息

Pediatr Res. 2025 Apr;97(5):1605-1611. doi: 10.1038/s41390-024-03535-3. Epub 2024 Sep 6.

Abstract

BACKGROUND

Steroid treatment is well-known for producing clinically significant improvements in respiratory support requirements. In this study, we utilized lung ultrasound and respiratory oscillometry to objectively assess this response and determine if the combination of these methods can serve as a valuable tool for comparing different treatment strategies.

METHODS

We conducted a retrospective observational study including preterm infants with a gestational age below 32 weeks and/or a birth weight below 1500 g. We measured lung ultrasound score (LUS) and respiratory system reactance (Xrs) by respiratory oscillometry before and after treatment with either systemic dexamethasone or inhaled budesonide.

RESULTS

We analyzed 46 treatments (9 dexamethasone, 37 budesonide) administered to 40 infants (median (Q1, Q3) postnatal age = 30 (18, 49) days, postmenstrual age = 33.29 (30.14, 35.00) weeks). All treatments were associated with a notable reduction in respiratory support and a concurrent improvement in either Xrs, LUS, or both. On average, Xrs improved from 3.13 (1.09, 5.41) to 0.44 (-0.90, 1.59) z-score (p < 0.001) and LUS from 10 (7, 12) to 5 (3, 8) (p < 0.001).

CONCLUSIONS

Xrs and LUS proved sensitive to lung function changes associated with corticosteroids; combining the two better described the response and its variability.

IMPACT

We found that respiratory system reactance (Xrs) and lung ultrasound score (LUS) are sensitive biomarker for monitoring changes in lung function associated with corticosteroids; Combining Xrs and LUS enhances evaluation compared to each method alone; These results have valuable implications in clinical practice, particularly in personalizing and monitoring corticosteroid treatment; The present paper suggests that the combined use of respiratory oscillometry and lung ultrasound holds value as a research tool in future studies investigating various treatment regimens, molecules, or administration routes.

摘要

背景

类固醇治疗以在呼吸支持需求方面产生具有临床意义的改善而闻名。在本研究中,我们利用肺部超声和呼吸振荡法来客观评估这种反应,并确定这些方法的组合是否可作为比较不同治疗策略的有价值工具。

方法

我们进行了一项回顾性观察研究,纳入孕周低于32周和/或出生体重低于1500克的早产儿。在用全身地塞米松或吸入布地奈德治疗前后,我们通过呼吸振荡法测量肺部超声评分(LUS)和呼吸系统电抗(Xrs)。

结果

我们分析了对40例婴儿进行的46次治疗(9次地塞米松治疗,37次布地奈德治疗)(中位(第一四分位数,第三四分位数)出生后年龄 = 30(18,49)天,月经后年龄 = 33.29(30.14,35.00)周)。所有治疗均与呼吸支持的显著减少以及Xrs、LUS或两者的同时改善相关。平均而言,Xrs的z评分从3.13(1.09,5.41)改善至0.44(-0.90,1.59)(p < 0.001),LUS从10(7,12)改善至5(3,8)(p < 0.001)。

结论

Xrs和LUS被证明对与皮质类固醇相关的肺功能变化敏感;将两者结合能更好地描述反应及其变异性。

影响

我们发现呼吸系统电抗(Xrs)和肺部超声评分(LUS)是监测与皮质类固醇相关的肺功能变化的敏感生物标志物;与单独使用每种方法相比,结合Xrs和LUS可增强评估;这些结果在临床实践中具有重要意义,特别是在皮质类固醇治疗的个性化和监测方面;本文表明,呼吸振荡法和肺部超声的联合使用作为一种研究工具,在未来研究各种治疗方案、分子或给药途径时具有价值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验